Binovi Technologies Corp. (BNVIF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Binovi Technologies Corp. (BNVIF) with AI Score 54/100 (Hold). Binovi Technologies Corp. develops and commercializes visual and neuro-cognitive processing products. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026Binovi Technologies Corp. (BNVIF) Healthcare & Pipeline Overview
Binovi Technologies Corp. focuses on visual and neuro-cognitive processing products, offering tools like Binovi Touch and Binovi Pro for vision therapy and training. The company operates in the healthcare information services sector, providing solutions for diagnosing and remediating visual perception disorders across Canada, the United States, and internationally.
Investment Thesis
Binovi Technologies Corp. operates in the niche market of visual and neuro-cognitive processing, presenting both opportunities and risks. The company's focus on developing and commercializing specialized hardware and software for vision therapy positions it to capitalize on the growing awareness of visual perception disorders. A key value driver is the potential expansion of Binovi's product line, particularly the successful launch of Binovi Agile and Binovi Connect, which could broaden its market reach and revenue streams. However, the company's negative profit margin of -8790.2% indicates significant challenges in achieving profitability. Upcoming catalysts include potential partnerships with vision care professionals and institutions, which could drive adoption of Binovi's products. Investors should closely monitor the company's ability to manage its operating expenses and achieve sustainable revenue growth.
Based on FMP financials and quantitative analysis
Key Highlights
- Binovi Technologies Corp. operates in the healthcare information services sector, focusing on visual and neuro-cognitive processing products.
- The company's gross margin stands at 70.7%, indicating a strong ability to control production costs.
- Binovi's product suite includes Binovi Touch, Binovi Pro, Binovi Coach, and Binovi Academy, catering to various aspects of vision therapy and training.
- The company is developing Binovi Agile and Binovi Connect to expand its product offerings and market reach.
- Binovi Technologies Corp. has a beta of 0.11, suggesting lower volatility compared to the overall market.
Competitors & Peers
Strengths
- Proprietary technology in visual and neuro-cognitive processing.
- Integrated hardware and software solutions.
- Comprehensive product suite including Binovi Touch, Pro, Coach, and Academy.
- Strong gross margin of 70.7%.
Weaknesses
- Negative profit margin of -8790.2%.
- Limited market capitalization of $0.00B.
- Dependence on successful product development and commercialization.
- OTC market listing presents liquidity and regulatory challenges.
Catalysts
- Upcoming: Potential partnerships with vision care professionals and institutions to drive product adoption.
- Upcoming: Successful launch of Binovi Agile to expand product offerings.
- Ongoing: Expansion of the Binovi Connect platform to increase remote vision care access.
- Ongoing: Enhancement of the Binovi Academy platform to attract more users.
- Ongoing: Geographic expansion into new markets in Europe and Asia.
Risks
- Ongoing: Negative profit margin of -8790.2% indicating financial instability.
- Potential: Competition from established players in the healthcare information services sector.
- Potential: Technological advancements rendering existing products obsolete.
- Potential: Regulatory changes impacting the vision therapy industry.
- Ongoing: Limited liquidity and transparency due to OTC market listing.
Growth Opportunities
- Expanding the Binovi Connect Platform: Binovi Connect, a web-based video conferencing solution, offers a significant growth opportunity by connecting consumers with vision care professionals remotely. The telemedicine market is projected to reach $460 billion by 2030, presenting a substantial addressable market. By enhancing the platform's features and expanding its network of professionals, Binovi can increase its user base and generate recurring revenue through subscription models. The timeline for realizing this growth is within the next 2-3 years.
- Developing and Launching Binovi Agile: The successful development and launch of Binovi Agile represents a key growth driver. This new product aims to enhance the company's existing offerings and attract a broader customer base. The market for cognitive training tools is expected to grow, driven by increasing awareness of cognitive health. A successful launch within the next year could significantly boost Binovi's revenue and market share. The company needs to focus on effective marketing and distribution strategies to maximize its impact.
- Strategic Partnerships with Vision Care Professionals: Forming strategic partnerships with vision care professionals and institutions can drive the adoption of Binovi's products. Collaborating with optometrists, ophthalmologists, and vision therapy centers can provide access to a wider patient base and increase brand awareness. These partnerships can also facilitate the integration of Binovi's solutions into existing clinical workflows. The timeline for establishing these partnerships is ongoing, with potential for significant impact within the next 1-2 years.
- Geographic Expansion into New Markets: Expanding into new geographic markets, particularly in Europe and Asia, presents a significant growth opportunity. The global market for vision therapy products is growing, driven by increasing awareness of visual perception disorders in these regions. By adapting its products to meet local needs and regulations, Binovi can tap into new revenue streams and diversify its customer base. This expansion could be phased over the next 3-5 years, starting with pilot programs in select countries.
- Enhancing the Binovi Academy Platform: Enhancing the Binovi Academy platform by adding more educational resources and training programs can attract more users and generate revenue through subscriptions and course fees. The market for online education in healthcare is growing, driven by the need for continuous professional development. By offering high-quality content and certifications, Binovi can establish itself as a leading provider of vision therapy education. The timeline for enhancing the platform is ongoing, with new content and features being added regularly.
Opportunities
- Expanding the Binovi Connect platform for remote vision care.
- Developing and launching Binovi Agile.
- Forming strategic partnerships with vision care professionals.
- Geographic expansion into new markets in Europe and Asia.
Threats
- Competition from established players in the healthcare information services sector.
- Technological advancements rendering existing products obsolete.
- Regulatory changes impacting the vision therapy industry.
- Economic downturn affecting healthcare spending.
Competitive Advantages
- Proprietary technology in visual and neuro-cognitive processing.
- Integrated hardware and software solutions.
- Established relationships with vision care professionals.
- Educational resources and training programs through Binovi Academy.
About BNVIF
Binovi Technologies Corp., formerly known as Eyecarrot Innovations Corp., was rebranded in June 2020 and is based in Vancouver, Canada. The company develops, manufactures, and commercializes a range of visual and neuro-cognitive processing products, encompassing both hardware and software solutions. These products are designed to diagnose and remediate visual perception disorders, addressing a critical need in vision care. Binovi's core offerings include Binovi Touch, a versatile tool used for vision therapy and training, providing interactive exercises and assessments. Binovi Pro is a software platform that enables doctors and trainers to efficiently manage patient or athlete vision training regimens. It facilitates progress tracking, protocol planning, and assignment, streamlining the therapeutic process. Binovi Coach complements these tools by allowing users to complete assigned activities through clear, multimedia guidance, enhancing engagement and adherence. Binovi Academy serves as an educational hub, providing resources and training materials for professionals and users alike. The company is also actively developing Binovi Agile and Binovi Connect, a web-based video conferencing solution designed to connect consumers with vision care professionals, expanding access to specialized care. Binovi Technologies operates in Canada, the United States, and internationally, aiming to improve visual health through innovative technology.
What They Do
- Develops visual and neuro-cognitive processing products.
- Manufactures hardware and software for vision therapy.
- Commercializes solutions for diagnosing visual perception disorders.
- Offers Binovi Touch for vision training exercises.
- Provides Binovi Pro for managing patient vision training regimens.
- Offers Binovi Coach for guided user activities.
- Maintains Binovi Academy as an educational hub.
Business Model
- Sells hardware and software products for vision therapy.
- Offers subscription-based access to Binovi Pro and Binovi Academy.
- Generates revenue through partnerships with vision care professionals.
- Provides training and educational resources for professionals and users.
Industry Context
Binovi Technologies Corp. operates within the healthcare information services sector, which is experiencing growth due to increasing demand for digital health solutions and remote patient monitoring. The market for vision therapy and training tools is expanding as awareness of visual perception disorders grows. The competitive landscape includes companies offering similar diagnostic and therapeutic solutions. Binovi differentiates itself through its integrated hardware and software approach, providing a comprehensive platform for vision care professionals. The industry is also influenced by technological advancements in virtual reality and augmented reality, which are being incorporated into vision therapy programs.
Key Customers
- Optometrists and ophthalmologists.
- Vision therapy centers and clinics.
- Athletic trainers and sports teams.
- Educational institutions and schools.
- Individuals seeking vision therapy solutions.
Financials
Chart & Info
Binovi Technologies Corp. (BNVIF) stock price: Price data unavailable
Latest News
No recent news available for BNVIF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BNVIF.
Price Targets
Wall Street price target analysis for BNVIF.
MoonshotScore
What does this score mean?
The MoonshotScore rates BNVIF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Jatinder Dhaliwal
CEO
Jatinder Dhaliwal is the CEO of Binovi Technologies Corp. His background includes experience in technology and business development. He has been involved in various leadership roles, focusing on strategic growth and innovation. Dhaliwal's expertise lies in identifying market opportunities and driving the commercialization of new products. His educational background includes studies in business administration and technology management. He brings a combination of technical knowledge and business acumen to his role at Binovi.
Track Record: Under Jatinder Dhaliwal's leadership, Binovi Technologies Corp. has focused on expanding its product line and market reach. Key achievements include the development of Binovi Connect and the enhancement of the Binovi Academy platform. Strategic decisions have centered on forming partnerships with vision care professionals and exploring new geographic markets. Dhaliwal has also overseen the rebranding of the company and the transition to its current focus on visual and neuro-cognitive processing solutions.
BNVIF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Binovi Technologies Corp. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may be subject to less regulatory oversight compared to those listed on major exchanges like the NYSE or NASDAQ. This tier typically includes companies that are defunct, in bankruptcy, or unwilling to provide current information to the public. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and potential for fraud.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to OTC Other tier listing.
- Lack of transparency and disclosure.
- Potential for price volatility.
- Higher risk of fraud or manipulation.
- Limited regulatory oversight.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Check for any legal or regulatory issues.
- Understand the risks associated with OTC investing.
- Consult with a financial advisor.
- Development of proprietary technology in visual processing.
- Partnerships with vision care professionals (if any can be verified).
- Presence of an educational platform (Binovi Academy).
- Commercialization of products like Binovi Touch and Binovi Pro.
Binovi Technologies Corp. Stock: Key Questions Answered
What does Binovi Technologies Corp. do?
Binovi Technologies Corp. develops, manufactures, and commercializes visual and neuro-cognitive processing products designed to diagnose and remediate visual perception disorders. Their offerings include hardware and software solutions like Binovi Touch, Binovi Pro, Binovi Coach, and Binovi Academy. These products cater to vision therapy, training, and educational needs, serving optometrists, ophthalmologists, athletic trainers, and individuals seeking vision improvement. The company operates in Canada, the United States, and internationally, aiming to enhance visual health through innovative technology.
What do analysts say about BNVIF stock?
As of 2026-03-17, there is no readily available analyst consensus on BNVIF stock due to its OTC listing and limited coverage. Key valuation metrics such as price-to-earnings ratio are not meaningful due to the company's negative earnings. Growth considerations center on the successful commercialization of new products like Binovi Agile and the expansion of the Binovi Connect platform. Investors should conduct their own thorough research and consider the risks associated with investing in OTC stocks before making any decisions.
What are the main risks for BNVIF?
The main risks for Binovi Technologies Corp. include its negative profit margin, which indicates financial instability and challenges in achieving profitability. Competition from established players in the healthcare information services sector poses a threat to market share. Technological advancements could render existing products obsolete, requiring continuous innovation. Regulatory changes in the vision therapy industry could impact the company's operations. The OTC market listing presents liquidity and transparency challenges, increasing the risk for investors.
What are the key factors to evaluate for BNVIF?
Binovi Technologies Corp. (BNVIF) currently holds an AI score of 54/100, indicating moderate score. Key strength: Proprietary technology in visual and neuro-cognitive processing.. Primary risk to monitor: Ongoing: Negative profit margin of -8790.2% indicating financial instability.. This is not financial advice.
How frequently does BNVIF data refresh on this page?
BNVIF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven BNVIF's recent stock price performance?
Recent price movement in Binovi Technologies Corp. (BNVIF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary technology in visual and neuro-cognitive processing.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider BNVIF overvalued or undervalued right now?
Determining whether Binovi Technologies Corp. (BNVIF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying BNVIF?
Before investing in Binovi Technologies Corp. (BNVIF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for OTC-listed companies.
- Financial data may not be up-to-date.
- Analyst coverage is limited.